News-Medical.Net on MSN
Cannabidiol shows promise for obesity and metabolic syndrome
Cannabidiol (CBD) shows promise in regulating appetite, glucose and lipid metabolism, and inflammation in preclinical models ...
GlyphAgo is an oral prodrug of agomelatine, a medicine with established clinical efficacy in four out of four previous third-party randomized, placebo-controlled studies in generalized anxiety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback